DICE Therapeutics Overview

DICE Therapeutics Operating Income

Operating Income for DICE.

Quarterly Operating Income

$-39497000.00

↑ 81.65% YoY

As of Jun 30, 2023

Annual Operating Income (TTM)

$-118691000.00

↑ 62.71% YoY

Trailing 12 months ending Jun 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin